[1] |
ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
[J]. China Oncology, 2022, 32(1): 1-12.
|
[2] |
YANG Shipeng , LIU Ying , WANG Xinyue , YANG Yang , QUAN Jishu , LIN Zhenhua .
Clinical significance of PKLR overexpression in the pancreatic cancer
[J]. China Oncology, 2021, 31(8): 704-713.
|
[3] |
XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia.
The advances in immunotherapy biomarkers of small cell lung cancer
[J]. China Oncology, 2021, 31(7): 635-639.
|
[4] |
TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
[J]. China Oncology, 2021, 31(1): 1-10.
|
[5] |
ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang .
Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer
[J]. China Oncology, 2020, 30(7): 519-524.
|
[6] |
ZHAO Haiyun, WU Xiaohua.
Research progress of immunotherapy in ovarian cancer
[J]. China Oncology, 2020, 30(7): 538-545.
|
[7] |
MAO Tiebo, CUI Jiujie, WANG Liwei.
Research progress in pancreatic cancer in 2019 from experimental study to clinical evaluation
[J]. China Oncology, 2020, 30(2): 81-89.
|
[8] |
NING Zhouyu, HUA Yongqiang, XU Litao, ZHUANG Liping, FENG Lanyun, CHEN Hao, WANG Peng, SHEN Yehua, LIN Junhua, CHEN Zhen, MENG Zhiqiang.
Efficacy and safety of nab-paclitaxel plus gemcitabine in the treatment of advanced pancreatic cancer by transcatheter arterial chemotherapy: a retrospective study
[J]. China Oncology, 2020, 30(2): 128-134.
|
[9] |
ZHU Xiaodong, CHEN Siyuan.
Combination therapy of immune checkpoint inhibitors: from rationale to practice
[J]. China Oncology, 2020, 30(12): 969-976.
|
[10] |
XU Wencai, GUO Leiming, CUI Yingying, LIU Xiao, JIANG Yue, GE Hong.
The effect of lung stereotactic body radiotherapy on peripheral blood lymphocytes
[J]. China Oncology, 2020, 30(12): 1013-1016.
|
[11] |
LI Guoyu , HE Ming .
New progress in the research of immunotherapy for extensive-stage small cell lung cancer
[J]. China Oncology, 2020, 30(10): 826-833.
|
[12] |
ZHU Xuqin,JIA Songlin,QI Jie,SHEN Xuefang,LONG Jiang,MIAO Changhong .
Perioperative factors associated with prognosis of patients after radical resection of pancreatic cancer: a retrospective analysis
[J]. China Oncology, 2019, 29(7): 521-527.
|
[13] |
PAN Yingying, ZHOU Fei, ZHOU Caicun.
The perspects and challenges of immunotherapy for lung cancer
[J]. China Oncology, 2019, 29(4): 241-249.
|
[14] |
CAO Xiaoshan, CONG Binbin.
The progress of treatment for triple-negative breast cancer in the era of precision medicine
[J]. China Oncology, 2019, 29(12): 971-976.
|
[15] |
YANG Yunsong, JIANG Yizhou, HU Xin, SHAO Zhimin.
Research progress of breast tumor microenvironment-targeted therapy
[J]. China Oncology, 2019, 29(12): 977-984.
|